Global MRI Safe Cardiac Resynchronization Therapy Device Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

MRI safe cardiac resynchronization therapy - Defibrillator and MRI safe cardiac resynchronization therapy - Pacemaker.

By Indication;

Cardiomyopathy, Bradycardia, Electrocardiography and Congestive Heart Failure.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn771964939 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global MRI Safe Cardiac Resynchronization Therapy Device Market (USD Million), 2021 - 2031

In the year 2024, the Global MRI Safe Cardiac Resynchronization Therapy Device Market was valued at USD 684.69 million. The size of this market is expected to increase to USD 1,324.79 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.9%.

The Global MRI Safe Cardiac Resynchronization Therapy (CRT) Device Market is a rapidly growing sector in the medical device industry. These devices are designed to manage heart failure by improving the timing of the heart's contractions through electrical impulses. Traditional CRT devices posed risks during MRI scans due to their metallic components and the strong magnetic fields involved in MRI procedures. However, MRI safe CRT devices are engineered to withstand these magnetic fields, allowing patients to undergo essential MRI scans without the risk of device malfunction or patient harm. The increasing prevalence of cardiovascular diseases, coupled with the aging global population, has significantly fueled the demand for these devices. Additionally, technological advancements have led to the development of more sophisticated and compatible CRT devices, enhancing patient outcomes and safety. The market is also driven by a greater focus on patient safety and the rising number of MRI procedures worldwide. Governments and healthcare organizations are investing heavily in advanced medical infrastructure and are encouraging the adoption of such innovative technologies. Despite the promising growth prospects, the market faces challenges such as high costs, limited reimbursement policies, and stringent regulatory requirements. Nonetheless, continuous research and development, along with strategic collaborations and expanding healthcare awareness, present numerous opportunities for market players. The evolution of personalized medicine and the integration of digital health solutions further contribute to the market's potential, making MRI safe CRT devices an essential component in the future of cardiac care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Region
  4. Global MRI Safe Cardiac Resynchronization Therapy Device Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements boost
        2. Growing cardiac diseases
        3. Increased MRI procedures
        4. Patient safety focus
        5. Healthcare expenditure rise
      2. Restraints
        1. High device cost
        2. Limited reimbursement policies
        3. Stringent regulatory requirements
        4. Skilled professionals shortage
        5. Complex implantation procedures
      3. Opportunities
        1. Emerging market expansion
        2. Research and development
        3. Technological innovations
        4. Strategic partnerships growth
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global MRI Safe Cardiac Resynchronization Therapy Device Market, By Product, 2021 - 2031 (USD Million)
      1. MRI safe cardiac resynchronization therapy - Defibrillator
      2. MRI safe cardiac resynchronization therapy - Pacemaker
    2. Global MRI Safe Cardiac Resynchronization Therapy Device Market, By Indication, 2021 - 2031 (USD Million)
      1. Cardiomyopathy
      2. Bradycardia
      3. Electrocardiography
      4. Congestive Heart Failure
    3. Global MRI Safe Cardiac Resynchronization Therapy Device Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. St. Jude Medical
      2. Abbott
      3. Medtronic
      4. Boston Scientific Corporation
      5. Cook Group, Scranton Gillette Communications
      6. Philips
      7. LivaNova
      8. MicroPort Scientific
      9. BIOTRONIK
      10. Medico
      11. Qinming Medical
  7. Analyst Views
  8. Future Outlook of the Market